Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.

Journal

Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 7 3 2019
medline: 7 3 2019
entrez: 7 3 2019
Statut: ppublish

Résumé

The original version of this Article contained an error in the Acknowledgements section.

Identifiants

DOI: 10.1038/s41375-019-0415-y PMID: 30837671
pubmed: 30837671
doi: 10.1038/s41375-019-0415-y
pii: 10.1038/s41375-019-0415-y
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1541

Commentaires et corrections

Type : ErratumFor

Auteurs

Jessica Barth (J)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.
German Cancer Consortium (DKTK), Frankfurt, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Khalil Abou-El-Ardat (K)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.
German Cancer Consortium (DKTK), Frankfurt, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Denis Dalic (D)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.

Nina Kurrle (N)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.

Anna-Maria Maier (AM)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.

Sebastian Mohr (S)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.

Judith Schütte (J)

Department of Medicine A, University Hospital Muenster, Muenster, Germany.

Lothar Vassen (L)

Department of Medicine A, University Hospital Muenster, Muenster, Germany.

Gabriele Greve (G)

German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), Freiburg, Germany.
Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg Medical Center, Freiburg, Germany.

Johannes Schulz-Fincke (J)

German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), Freiburg, Germany.
Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany.

Martin Schmitt (M)

Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany.

Milica Tosic (M)

Department of Urology and Center for Clinical Research, University of Freiburg Medical Center, Freiburg, Germany.

Eric Metzger (E)

Department of Urology and Center for Clinical Research, University of Freiburg Medical Center, Freiburg, Germany.

Gesine Bug (G)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.
German Cancer Consortium (DKTK), Frankfurt, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Cyrus Khandanpour (C)

Department of Medicine A, University Hospital Muenster, Muenster, Germany.
ORCID: 0000-0003-4655-6269

Sebastian A Wagner (SA)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.
German Cancer Consortium (DKTK), Frankfurt, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Michael Lübbert (M)

German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), Freiburg, Germany.
Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg Medical Center, Freiburg, Germany.

Manfred Jung (M)

German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), Freiburg, Germany.
Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany.

Hubert Serve (H)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.
German Cancer Consortium (DKTK), Frankfurt, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Roland Schüle (R)

Department of Urology and Center for Clinical Research, University of Freiburg Medical Center, Freiburg, Germany.
BIOSS Centre for Biological Signalling Studies, Albert-Ludwigs-University, 79104, Freiburg, Germany.

Tobias Berg (T)

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany. tobias.berg@kgu.de.
German Cancer Consortium (DKTK), Frankfurt, Germany. tobias.berg@kgu.de.
German Cancer Research Center (DKFZ), Heidelberg, Germany. tobias.berg@kgu.de.

Classifications MeSH